Chord Therapeutics

Developer of drugs for the treatment of rare neurological diseases

placePlan Les Ouates, Geneva, Switzerland calendar_todayFounded 2014 groups3 employees language chordtherapeutics.com

Innovation

3 patent families (2 granted) — focus: Human necessities; filing pace steady. Cited 54 times.

YearFilings
20191
20211
20221
20232
20242
20251

Investor mix

3 investors on record; lead investors include Omega Funds.

Investor typeCountShare
Venture capital267%
Accelerator & incubator133%
Coming soon